Last updated on August 2018

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-treatment, 2-stage, Dose-finding Study Evaluating the Efficacy and Safety of BOTOX® Intravesical Instillation in Participants with Overactive Bladder and Urinary Incontinence


Brief description of study

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-treatment, 2-stage, Dose-finding Study Evaluating the Efficacy and Safety of BOTOX® Intravesical Instillation in Participants with Overactive Bladder and Urinary Incontinence

Detailed Study Description

Key Inclusion Criteria:

  • Has symptoms of OAB (frequency and urgency) with urgency urinary incontinence for a period of at least 6 months immediately prior to screening

Clinical Study Identifier: TX152811

Contact Investigators or Research Sites near you

Start Over

Michael Yang

Manhattan Medical Research
New York, NY USA
  Connect »